Key facts
- This page summarizes Choo Chee Kong's Form 3 filing for CytoMed Therapeutics Ltd (GDTC).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 14 Apr 2023, 16:59.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
Consists of 2,559,482 Ordinary Shares held by Glorious Finance Limited ("Glorious Finance"). Mr. CHOO Chee Kong does not directly hold any shares in our Company but is deemed to beneficially own the shares held by Glorious Finance as indicated in the table above. Mr. CHOO Chee Kong owns 55.0% of shares in Glorious Finance. Glorious Finance is a major shareholder of the Company.
Footnote F2
Consists of 410,515 Ordinary Shares held by EP Capital Inc. ("EP Capital"). Mr. CHOO Chee Kong does not directly hold any shares in our Company but is deemed to beneficially own the shares held by EP Capital as indicated in the table above. Mr. CHOO Chee Kong owns 100.0% of shares in EP Capital.